Neurology ReviewsSiponimod Improves MRI Outcomes in Patients With Secondary Progressive MSNovember 22, 2017Multiple Sclerosis
Neurology ReviewsHighlights From the 7th Joint ECTRIMS‑ACTRIMS MeetingNovember 20, 2017Multiple Sclerosis
Neurology ReviewsMS Treatment Decisions Based on Milestones That MatterNovember 2, 2017Multiple Sclerosis
Neurology ReviewsDurable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-UpNovember 2, 2017Multiple Sclerosis
Neurology ReviewsHow Does Cladribine Compare With Other MS Therapies?October 27, 2017Multiple Sclerosis
Neurology ReviewsThe Expanded Timed Get Up and Go Test Predicts MS Disability October 27, 2017Multiple Sclerosis
Neurology ReviewsOligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MSOctober 25, 2017Multiple Sclerosis
Neurology ReviewsDMTs Reduce the Risk of Conversion to Secondary Progressive MSOctober 25, 2017Multiple Sclerosis
Neurology ReviewsThe Diagnostic Value of 2010 McDonald Criteria Versus 2016 MAGNIMS Guidelines for Special MS PopulationsOctober 25, 2017Multiple Sclerosis
